The Food and Drug Administration () is receiving mounting opposition to its approval of fourth vaccine doses for all Americans aged 50 and older. The agency broke standard practice when it made the decision last month, electing not to take advise from a panel of independent experts. Now, experts, including some that would have been on that panel, are criticizing the decision.Dr Marty Makary, a medical commentator and public policy expert from Johns Hopkins University, wrote an op-ed for the this week criticizing the FDA and its lack of transparency in the process of approving the additional shot.The FDA made the decision quickly, only days after applications were submitted for review, and it also granted a wider eligibility for its approval than the firm asked for.
Load More
Load More